{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:10:05Z","timestamp":1773789005576,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd001925","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2005,10,19]],"date-time":"2005-10-19T00:00:00Z","timestamp":1129680000000}}],"reference-count":27,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001925.pub2","type":"journal-article","created":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T07:54:39Z","timestamp":1128671679000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks"],"prefix":"10.1002","volume":"2011","author":[{"given":"Maria I","family":"Aguilar","sequence":"first","affiliation":[{"name":"Mayo Clinic Arizona; Department of Neurology; 5777 E. Mayo Boulevard Phoenix Arizona USA 85022"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hart","sequence":"additional","affiliation":[{"name":"University of Texas Health Science Center at San Antonio; Division of Neurology, Department of Medicine; 7703 Floyd Curl Drive San Antonio Texas USA 78284-7883"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,10,19]]},"reference":[{"key":"10.1002\/14651858.CD001925.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0003|cit2","unstructured":"Posada IS Low-dose aspirin, stroke, atrial fibrillation (LASAF) trial Personal communication 2004"},{"issue":"abstract supple","key":"10.1002\/14651858.CD001925.pub2-BIB0002|cit3","first-page":"311","article-title":"Alternate-day dosing of aspirin in atrial fibrillation","volume":"17","author":"Posada","year":"1999","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2796.2003.01159.x","article-title":"Effects of low-dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation","volume":"254","author":"Edvardsson","year":"2003","journal-title":"Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"The Stroke Prevention in Atrial Fibrillation Study: Final results","volume":"84","author":"Stroke Prevention in Atrial Fibrillation Investigators","year":"1991","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","article-title":"Secondary prevention of vascular events in patients with nonrheumatic atrial fibrillation and recent transient ischemic attack or minor ischemic stroke","volume":"342","author":"European Atrial Fibrillation Trial Study Group","year":"1993","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0007|cit7","first-page":"112","article-title":"Antiplatelet therapy to prevent stroke: risk of brain hemorrhage and efficacy in atrial fibrillation","volume":"153","author":"Diener","year":"1997","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1161\/01.CIR.87.1.162","article-title":"Indobufen in the prevention of thromboembolic complications in patients with heart disease. A randomized, placebo-controlled, double-blind study","volume":"87","author":"Fornaro","year":"1993","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0009|cit9","first-page":"8","article-title":"The Turkish atrial fibrillation study","volume":"28","author":"Yigit","year":"2000","journal-title":"Turk Kardiyoloji Dernegi Arsivi"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/jnnp.54.12.1044","article-title":"The United Kingdom Transient Ischemic Attack (UK-TIA) aspirin trial: final results","volume":"54","author":"UK-TIA Study Group","year":"1991","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0011|cit11","unstructured":"Sato H Ishikawa K Kitabatake A Low-dose aspirin for prevention of stroke in patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial Submitted for publication"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0012|cit12","first-page":"1949","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized clinical trials","volume":"154","author":"Atrial Fibrillation Investigators","year":"1994","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists' Collaboration","year":"2002","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation","volume":"155","author":"Feinberg","year":"1995","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","article-title":"Selecting patients with atrial fibrillation for anticoagulation. Stroke risk stratification in patients taking aspirin","volume":"110","author":"Gage","year":"2004","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.290.20.2685","article-title":"Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice","volume":"290","author":"Go","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7326\/0003-4819-128-5-199803010-00012","article-title":"Intensity of anticoagulation to prevent stroke in patients with atrial fibrillation","volume":"128","author":"Hart","year":"1998","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.STR.30.6.1223","article-title":"Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: Analysis of 2012 participants in the SPAF I-III clinical trials","volume":"30","author":"Hart","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.7326\/0003-4819-138-10-200305200-00011","article-title":"Lessons from the stroke prevention in atrial fibrillation trials","volume":"138","author":"Hart","year":"2003","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0023|cit23","first-page":"482","article-title":"Letter to the Editor","volume":"323","author":"Petersen","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1001\/jama.288.19.2441","article-title":"Oral anticoagulants vs. aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis","volume":"288","author":"Walraven","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.290.8.1049","article-title":"A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community. The Framingham Heart Study","volume":"290","author":"Wang","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001925.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: The Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001925.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:17:42Z","timestamp":1754497062000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001925.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Stroke Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2005,10,19]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001925.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,19]]}}}